HEOR

Showing 6 posts of 6 posts found.

capture

The economics of mental health

October 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, health economics and outcomes research, mental health, pharma

Louis Goss examines mental health from a health economics and outcomes research (HEOR) perspective and asks what might be done …

Nucala

Researchers question price of GSK’s Nucala

December 23, 2015
Research and Development GSK, HEOR, ICER, Nucala, asthma, cost-effective, health economics, health economics outcomes research

GSK is charging up to four times more for its recently approved asthma drug Nucala than is justified by cost-effectiveness …

Victoza

Novo Nordisk looks to HEOR data to back Victoza

November 11, 2015
Research and Development, Sales and Marketing Byetta, HEOR, Lyxumia, NHS, Novo Nordisk, Victoza, cost-effectiveness

A Novo Nordisk-sponsored study of the cost-effectiveness of three different injectable anti-diabetes drugs has found Victoza is a cheaper option …

Health Economics and Outcomes Research – What’s the Value?

July 2, 2012
Medical Communications HEOR, clinical evidence, economic evidence, market access, value

Pricing pressure and regulatory restrictions across various healthcare industries have called for more detailed evidence of outcomes

Measuring Return on Investment of Health Economics and Outcomes Research through the Cloud

July 2, 2012
Medical Communications HEOR, ROI, interactive tools, market access

Health economics and outcomes research (HEOR) is a young and fascinating area of research with an engaged academic community. Methodology …

Latest content